Free Trial
NASDAQ:INVO

INVO Bioscience Q4 2023 Earnings Report

INVO Bioscience logo
$1.65 -0.03 (-1.79%)
As of 05/27/2025

INVO Bioscience EPS Results

Actual EPS
-$0.42
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Bioscience Revenue Results

Actual Revenue
$1.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Bioscience Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

INVO Bioscience Earnings Headlines

The most explosive assets in 2025?
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
See More INVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Bioscience and other key companies, straight to your email.

About INVO Bioscience

INVO Bioscience (NASDAQ:INVO), together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Bioscience Profile

More Earnings Resources from MarketBeat